Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance-Reference-Cited by-同舟云学术

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

Published:2017-02-25 Issue:1 Volume:65 Page:110-120
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Haidar Ghady¹,Philips Nathan J²,Shields Ryan K¹³⁴,Snyder Daniel²,Cheng Shaoji⁴,Potoski Brian A¹³⁵,Doi Yohei¹,Hao Binghua⁴,Press Ellen G¹,Cooper Vaughn S²,Clancy Cornelius J¹⁴⁶,Nguyen M Hong¹³⁴

Affiliation:

1. Department of Medicine, University of Pittsburgh,

2. Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine,

3. Antibiotic Management Program, and

4. XDR Pathogen Laboratory, University of Pittsburgh Medical Center,

5. Department of Pharmacy and Therapeutics, University of Pittsburgh, and

6. VA Pittsburgh Healthcare System, Pennsylvania

Funder

National Institutes of Health

U.S. Department of Veterans Affairs

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/65/1/110/24266228/cix182.pdf

Reference60 articles.

1. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes;Tam;Antimicrob Agents Chemother,2010

2. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality;Tumbarello;Epidemiol Infect,2011

3. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study;Zavascki;Crit Care,2006

4. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes;Hirsch;Expert Rev Pharmacoecon Outcomes Res,2010

5. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact;Aloush;Antimicrob Agents Chemother,2006

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance;Journal of Global Antimicrobial Resistance;2024-09

2. Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against Pseudomonas aeruginosa by Inhibiting Drug Efflux;Antibiotics;2024-08-26

3. Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis;Acta Biomaterialia;2024-08

4. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia;Antibiotics;2024-07-05

5. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07